"Effect of the
Medicare Part D Coverage Gap on Medication Use among Patients with Hypertension and Hyperlipidemia." Annals of Internal Medicine 156 (11): 776, 84, W-263, W-264, W-265, W-266, W-267, W-268, W-269.
WASHINGTON -- Starting next year, the nation's pharmaceutical manufacturers will provide 50% discounts on the cost of covered branded prescription drugs to beneficiaries in the
Medicare Part D coverage gap, the so-called doughnut hole.
* Require pharmaceutical manufacturers to offer a 50 percent discount on brand-name prescriptions filled in the Medicare Part D coverage gap beginning in 2011, and begin phasing in federal subsidies for generic prescriptions filled in the Medicare Part D coverage gap.
* Begin phasing in federal subsidies for brand-name prescriptions filled in the Medicare Part D coverage gap.
"Medicare Part D Coverage Gap: Race, Gender, and Cost-Related Medication Nonadherence." Social Work in Public Health 30 (6): 473-85.
"Effects of Medicare Part D Coverage Gap on Medication Adherence." The American Journal of Managed Care 19 (6): e214-24.
"Effects of Medicare Part D Coverage Gap on Medication and Medical Treatment among Elderly Beneficiaries with Depression." Archives of General Psychiatry 69 (7): 6729.
Understanding the Effects of the
Medicare Part D Coverage Gap in 2008 and 2009: Cost and Consequences Prior to Improvements in Coverage Established by the 2010 Health Reform Law.
We examined the effect of the
Medicare Part D coverage gap on drug costs and adherence among beneficiaries with diabetes in two large health systems offering MAPD plans.